To procure crispr gene-editing of the ACVR1 and TGFBR1 genes in endometrial cancer cell lines for nhgri.
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00258
- Awardee
-
Synthego Corporation UEI RNDBNJAKTJC9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $86,750
Award facts
- Opportunity
-
- CRISPR gene-editing of the ACVR1 and TGFBR1 genes Solicitation · 75N92021Q0172 · Posted Jul 22, 2021
- CRISPR gene-editing of the ACVR1 and TGFBR1 genes Award Notice · Posted Jul 29, 2021
- Contract value 100% obligated
- $86,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Redwood City, CA 94063, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $86,750 |
About this award
The National Human Genome Research Institute (NHGRI), a civilian agency within the Department of Health and Human Services, has awarded a $86,750.00 firm fixed price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products located in Redwood City, California. The contract is for CRISPR gene-editing of the ACVR1 and TGFBR1 genes in endometrial cancer cell lines to support NHGRI's research objectives. This contract was competitively awarded under a solicitation that did not use any set-aside designation, and it has an ultimate completion date of August 2, 2024. Synthego has been awarded over 30 prime federal contracts, primarily from NIH institutes, to provide genome engineering solutions including custom cell lines, gene knockout/knock-in services, and CRISPR libraries and reagents.
Quick answers
Who was awarded contract 75N92021P00258?
75N92021P00258 was awarded to Synthego Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on August 2, 2021.
How much is contract 75N92021P00258 worth?
The government has obligated $86,750 on 75N92021P00258.
Which agency awarded contract 75N92021P00258?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021P00258, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92021P00258 competed?
The extent of competition for 75N92021P00258 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award